Last reviewed · How we verify

NCT06694194: GDBlung70

Global, Regional, and National Burdens and Trends of Tracheal, Bronchial, and Lung Cancer in Individuals Aged 70 Years and Older from 1990 to 2021

Completed Last updated 19 November 2024
What this trial tests

trial in Lung Cancer Patients in 111,627 participants. Completed in 10 October 2024.

Timeline
1 January 1990
Primary endpoint
10 October 2024
10 October 2024

Quick facts

Lead sponsorHongquan Xing
StatusCompleted
Study typeOBSERVATIONAL
Enrollment111,627
Start date1 January 1990
Primary completion10 October 2024
Estimated completion10 October 2024

Conditions studied

Sponsor

Hongquan Xing

Who can join

Eligibility, any sex, with Lung Cancer Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Despite the increasing health burden of tracheal, bronchial, and lung (TBL) cancer patients aged ≥ 70 years worldwide, data on its burden and trends are limited. This study aimed to analyze the global, regional, and national burdens and trends of TBL cancer from 1990 to 2021.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Lung Cancer Patients

Currently open trials in the same condition.

Other Hongquan Xing trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06694194.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing